The US Food and Drug Administration (FDA) has approved a groundbreaking medical device that offers new hope to patients living with rheumatoid arthritis (RA) — a chronic, often treatment-resistant autoimmune condition typically managed with medications. Unlike standard drugs, the device harnesses the brain and nervous system to control the uncontrolled inflammation that damages joints.
How the SetPoint System Works
The SetPoint System is a one-inch implant surgically placed in the neck. It sits in a small pod wrapped around the vagus nerve — believed to be the longest nerve in the body. Once implanted, it delivers a one-minute daily electrical stimulation. Research shows this stimulation can switch off harmful inflammation and “reset” the immune system. Unlike most RA drugs, which suppress immunity and increase infection risk, the SetPoint system aims to restore balance without weakening the body’s defences.
A Paradigm Shift in RA Treatment
On the American College of Rheumatology’s podcast, experts called the SetPoint implant a “true paradigm shift” in managing RA. Until now, treatment has relied almost entirely on pharmaceuticals, from early gold salts to advanced biologics. The FDA designated the implant as a breakthrough device in 2024, fast-tracking its development and approval. This innovation is also an early milestone in the emerging field of bioelectronic medicine, which targets inflammation linked to conditions such as diabetes, heart disease and cancer.
Expanding Research into Other Diseases
Clinical trials are already exploring vagus nerve stimulation for other inflammatory conditions, including inflammatory bowel disease in children, lupus, and multiple sclerosis. Trials for Crohn’s disease are also in the pipeline.
Strong Results in Clinical Trials
In a yearlong randomised controlled trial involving 242 patients, over half of those using the SetPoint implant alone achieved remission or saw significant improvement. Joint pain dropped by 60% and swelling by 63%. However, the FDA noted that long-term safety and effectiveness outside trial conditions remain unknown. The approval requires ongoing post-market monitoring for adverse events, particularly serious infections that can occur after implant surgeries.
A Life-Changing Impact for Patients
For 58-year-old speech pathologist Dawn Steiner, who joined the trial after 15 years of battling RA, the results have been dramatic. “Before the implant, I was living with pain at a six or seven on a scale of 10,” she said. “Now I’m about a two.” She had previously tried eight different biologic drugs without lasting relief.
Decades of Research Behind the Device
As reported by TOI, the device is the result of decades of research led by neurosurgeon Dr Kevin J. Tracey, president and CEO of the Feinstein Institutes for Medical Research at Northwell Health. Tracey co-founded SetPoint Medical and now serves as an adviser. He compares the vagus nerve to an “on-off switch” for immune system activity. “The brain can turn off inflammation as long as the vagus nerve is intact,” he explained. “It’s like a brake system in your car.”
Re-Educating the Immune System
According to Dr David Chernoff, SetPoint Medical’s chief medical officer, the approach is entirely different from conventional drug therapy. “Drugs block one pathway contributing to joint damage,” he said. “We’re re-educating the immune system through the brain to behave differently — without blocking its ability to fight infection.” Tracey added that some inflammation is essential for wound healing, fighting infections, and tissue repair.
Cost and Durability
The device’s price has not yet been disclosed, but a company spokesperson said it is designed to last 10 years and will be less expensive than a year’s supply of some RA drugs, which can be prohibitively costly.
Cautious Optimism in the Medical Community
Some experts remain cautiously optimistic. Dr Lou Bridges, chief of rheumatology at the Hospital for Special Surgery and NewYork-Presbyterian/Weill Cornell Medical Center, said, “It’s still early days. The proof will be in the pudding. I hope this is a revolutionary way to treat RA without drugs and side effects — but I’ve heard this story before.”